Literature DB >> 20617407

Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons.

R E J Musgrove1, A E King, T C Dickson.   

Abstract

α-Synuclein is the major protein component of Lewy bodies--the pathological hallmark of Parkinson's disease (PD) and Dementia with Lewy bodies (DLB). Its accumulation into intracellular aggregates is implicated in the process of Lewy body formation. However, its roles in both normal function, and disease, remain controversial. Using a novel model of chronic oxidative stress in cultured dopaminergic and cortical neurons, we report that endogenous α-synuclein is upregulated in response to low dose toxicity. This response is conserved between subpopulations of cortical and dopaminergic neurons, and confers relative resistance to apoptosis following secondary insult. Additional acute oxidative stress leads to intracellular accumulation of α-synuclein. These punctate deposits colocalize with ubiquitin, which is central to proteosome-mediated protein degeneration, and is the second major component of Lewy bodies. The current results imply that differential levels of α-synuclein expression may influence neuronal vulnerability in chronic neurodegenerative diseases. They further support a 'two hit' hypothesis for Lewy body formation, whereby mild stress causes a protective upregulation of α-synuclein. However, such increased levels of α-synuclein may drive its accumulation, following additional toxic insult. Finally, these results support a common mechanism for degeneration of dopaminergic and cortical neurons, affected in PD, and DLB, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617407     DOI: 10.1007/s12640-010-9207-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  42 in total

1.  Parkinson's disease and dementia with Lewy bodies: one disease or two?

Authors:  Irene Hegeman Richard; Michelle Papka; Ana Rubio; Roger Kurlan
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

2.  Binding partners L1 cell adhesion molecule and the ezrin-radixin-moesin (ERM) proteins are involved in development and the regenerative response to injury of hippocampal and cortical neurons.

Authors:  Matilda A Haas; James C Vickers; Tracey C Dickson
Journal:  Eur J Neurosci       Date:  2004-09       Impact factor: 3.386

3.  The exacerbation of hippocampal excitotoxicity by glucocorticoids is not mediated by apoptosis.

Authors:  Madhuri Roy; Robert M Sapolsky
Journal:  Neuroendocrinology       Date:  2003-01       Impact factor: 4.914

4.  Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

Authors:  M Hashimoto; L J Hsu; Y Xia; A Takeda; A Sisk; M Sundsmo; E Masliah
Journal:  Neuroreport       Date:  1999-03-17       Impact factor: 1.837

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture.

Authors:  Wenbo Zhou; Jerome Schaack; W Michael Zawada; Curt R Freed
Journal:  Brain Res       Date:  2002-02-01       Impact factor: 3.252

7.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

8.  Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection.

Authors:  M C Quilty; A E King; W-P Gai; D L Pountney; A K West; J C Vickers; T C Dickson
Journal:  Exp Neurol       Date:  2005-11-28       Impact factor: 5.330

9.  alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons.

Authors:  Hardy J Rideout; Paula Dietrich; Qiaohong Wang; William T Dauer; Leonidas Stefanis
Journal:  J Biol Chem       Date:  2004-08-18       Impact factor: 5.157

10.  Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells.

Authors:  Marco Bisaglia; Elisa Greggio; Dragan Maric; David W Miller; Mark R Cookson; Luigi Bubacco
Journal:  BMC Neurosci       Date:  2010-03-25       Impact factor: 3.288

View more
  9 in total

1.  Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.

Authors:  Vedad Delic; Jeddidiah W D Griffin; Sandra Zivkovic; Yumeng Zhang; Tam-Anh Phan; Henry Gong; Dale Chaput; Christian Reynes; Vinh B Dinh; Josean Cruz; Eni Cvitkovic; Devon Placides; Ernide Frederic; Hamed Mirzaei; Stanley M Stevens; Umesh Jinwal; Daniel C Lee; Patrick C Bradshaw
Journal:  Neuromolecular Med       Date:  2017-06-15       Impact factor: 3.843

2.  Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways.

Authors:  L N Saligan; C P Hsiao; D Wang; X M Wang; L St John; A Kaushal; D Citrin; J J Barb; P J Munson; R A Dionne
Journal:  Brain Behav Immun       Date:  2012-09-26       Impact factor: 7.217

3.  α-Synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK signalling pathway.

Authors:  Ruth E J Musgrove; Anna E King; Tracey C Dickson
Journal:  Neurotox Res       Date:  2012-08-31       Impact factor: 3.911

4.  Effect of α-synuclein on amyloid β-induced toxicity: relevance to Lewy body variant of Alzheimer disease.

Authors:  Rosa Resende; Sueli C F Marques; Elisabete Ferreiro; Isaura Simões; Catarina R Oliveira; Cláudia M F Pereira
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

5.  αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?

Authors:  David Protter; Charmaine Lang; Antony A Cooper
Journal:  Parkinsons Dis       Date:  2012-06-10

6.  Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates.

Authors:  Timothy J Collier; D Eugene Redmond; Kathy Steece-Collier; Jack W Lipton; Fredric P Manfredsson
Journal:  Front Neurosci       Date:  2016-01-29       Impact factor: 4.677

7.  Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models.

Authors:  Jin Young Shin; Dong-Yeol Kim; Jieun Lee; Yu Jin Shin; Yi Seul Kim; Phil Hyu Lee
Journal:  Stem Cell Res Ther       Date:  2022-09-24       Impact factor: 8.079

8.  Dopamine Cytotoxicity Involves Both Oxidative and Nonoxidative Pathways in SH-SY5Y Cells: Potential Role of Alpha-Synuclein Overexpression and Proteasomal Inhibition in the Etiopathogenesis of Parkinson's Disease.

Authors:  Kalpita Banerjee; Soumyabrata Munshi; Oishimaya Sen; Vishmadeb Pramanik; Tapasi Roy Mukherjee; Sasanka Chakrabarti
Journal:  Parkinsons Dis       Date:  2014-04-02

Review 9.  Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson's Disease?

Authors:  Christian U von Linstow; Merritt DeLano-Taylor; Jeffrey H Kordower; Patrik Brundin
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.